Management of Failed DVT Prophylaxis

Initial Assessment

The American Society of Hematology recommends confirming patient compliance with the prescribed prophylactic regimen, verifying that the medication and dosing were appropriate for the individual patient, and checking the International Normalized Ratio (INR) to confirm therapeutic anticoagulation for patients on vitamin K antagonists (VKAs) 1
Evaluate for underlying conditions that may have contributed to prophylaxis failure, such as antiphospholipid syndrome 1 and vasculitis 2
Consider drug-drug or drug-food interactions as a potential cause of prophylaxis failure 1

For patients on VKA therapy who experience breakthrough VTE, rule out heparin-induced thrombocytopenia (HIT) and consider switching to low-molecular-weight heparin (LMWH) over direct oral anticoagulants (DOACs) (conditional recommendation based on very low certainty evidence) 1
For patients on DOACs who experience breakthrough VTE, consider switching to LMWH, especially if there are concerns about underlying conditions like antiphospholipid syndrome 1

The American College of Chest Physicians recommends continuing antithrombotic therapy rather than stopping after completing primary treatment for patients with VTE provoked by a transient risk factor who have a history of previous unprovoked VTE or VTE provoked by a chronic risk factor 1
For patients with unprovoked VTE, treat with anticoagulation for at least 3 months and evaluate for extended therapy based on risk-benefit ratio 3

The American College of Cardiology recommends using Inferior Vena Cava (IVC) filters only for patients with acute proximal DVT or PE who have a contraindication to anticoagulation 2
Avoid using IVC filters in addition to anticoagulants for patients with acute DVT of the leg 3
Consider compression stockings (30-40 mm Hg knee high) for 2 years to reduce the risk of post-thrombotic syndrome 2
For patients with acute symptomatic DVT of the leg, early ambulation is preferred over initial bed rest 3

Do not assume non-compliance as the cause of failed prophylaxis without thorough investigation of other potential causes 1
Recognize that certain conditions (e.g., antiphospholipid syndrome) may respond better to specific anticoagulants (LMWH preferred over DOACs) 1
Avoid premature discontinuation of anticoagulation therapy, as this may lead to recurrent VTE 3